Thomas Ciulla

Company: Clearside Biomedical

Job title: Chief Medical & Development Officer, Executive Vice President

Seminars:

Overcoming Translatability, Durability & Delivery Challenges to Progress Safe, Efficacious, & Non-Invasive Retinal Vascular Therapeutics to Address a Significant Unmet Medical Need 10:30 am

Reducing the Treatment Burden for Wet AMD, DME, DR & RVO Patients Developing a Novel Therapeutic to Potentially Treat DME Patients that are Non-Responsive to Anti-VEGF Therapy Exploring why some patients with DME do not respond to anti-VEGF therapy and the complications this causes in the clinic. Discussing the development of a novel therapeutic to…Read more

day: Day Two